drugset
drugset / Trial / NCT02752087

A Study to Compare the Effects of a Test and Reference Formulation of LY900014 in Healthy Participants

NCT02752087 ↗

Phase 1 Completed 24 enrolled Eli Lilly and Company
RandomizedCrossoverOpen-labelBasic science

Summary

This study of healthy participants evaluated the concentration of a test LY900014 and a reference LY900014 formulation in the bloodstream and how it affected the blood sugar levels. The whole study, including screening, took up to 8 weeks to complete.

Timeline

Start
2016-04
Primary completion
2016-05
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Lispro Protein / enzyme biologic — Subcutaneous

Indications

No indication recorded.